We found a significant association between RNF31 expression and different molecular subtypes of adrenocortical carcinoma (ACC), BRCA, COAD, ESCA, brain lower grade glioma (LGG), OV, PCPG, PRAD, STAD and UCEC. Here, RNF31 is linked to adrenal cortex carcinoma.